Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126831962 | 12683196 | 2 | F | 20160819 | 20160825 | 20160826 | EXP | PHHY2016US115126 | SANDOZ | COOPER JJ, GRANT J. REFRACTORY OCD DUE TO THALAMIC INFARCT WITH RESPONSE TO DRONABINOL. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2016;1-2 | 24.00 | YR | M | Y | 0.00000 | 20160826 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126831962 | 12683196 | 1 | SS | CLOMIPRAMINE | CLOMIPRAMINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 3 | SS | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 4 | PS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | UNK | U | 74925 | |||||||||
| 126831962 | 12683196 | 5 | SS | FLUVOXAMINE | FLUVOXAMINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 6 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 7 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 8 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 9 | SS | ZIPRASIDONE. | ZIPRASIDONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 10 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 11 | SS | QUETIAPINE. | QUETIAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 12 | SS | MEMANTINE. | MEMANTINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 13 | SS | KETAMINE | KETAMINE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 14 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126831962 | 12683196 | 15 | SS | N-ACETYLCYSTEINE | ACETYLCYSTEINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126831962 | 12683196 | 1 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 2 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 3 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 4 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 5 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 6 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 7 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 8 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 9 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 10 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 11 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 12 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 13 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 14 | Obsessive-compulsive disorder |
| 126831962 | 12683196 | 15 | Obsessive-compulsive disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126831962 | 12683196 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126831962 | 12683196 | Obsessive-compulsive disorder | |
| 126831962 | 12683196 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |